| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |